SG Americas Securities
ASMB icon

SG Americas Securities’s Assembly Biosciences ASMB Stock Holding History

SG Americas Securities’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000
Closed -$280K – 2704
2020
Q2 		$280K Buy
1,000
+103
+11% +$24K ﹤0.01% 2559
2020
Q1 		$160K Sell
897
-6,845
-88% -$1.47M ﹤0.01% 2670
2019
Q4 		$1.9M Buy
+7,742
New +$1.43M 0.02% 854
2019
Q3 		– Sell
-1,199
Closed -$194K – 2990
2019
Q2 		$194K Buy
+1,199
New +$228K ﹤0.01% 2427

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SG Americas Securities's ASMB Position: Q3 2020 in Review

SG Americas Securities sold out of Assembly Biosciences (ASMB) in Q3 2020, closing a stake of 1,000 shares — an estimated $280K sold.

SG Americas Securities first reported a position in ASMB in Q2 2019 and held it in 4 quarters. The position peaked at $1.9M in Q4 2019. 118 funds tracked by Wall St. Rank hold ASMB as of Q3 2020.

  • SG Americas Securities reported no remaining Assembly Biosciences position as of Q3 2020 after selling out during the quarter.
  • SG Americas Securities sold 1,000 Assembly Biosciences shares in Q3 2020, an estimated $280K.
  • SG Americas Securities first reported a position in Assembly Biosciences in Q2 2019 and held it in 4 quarters.
  • SG Americas Securities's Assembly Biosciences position peaked at $1.9M in Q4 2019.
  • 118 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.